AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Teladoc Health, Inc.
XNYS · usd
SIC 8011 · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
FIGI BBG001TG5PC6
6.34▲ 0.02 (0.32%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
6.32
Day's Range
6.20 – 6.39
52-Week Range
4.40 – 9.89
Volume
2.5M
Avg Volume
3.5M
Share Statistics
Shares Outstanding
Employees
5,600
Exchange
XNYS
Listed
2015-07-01
Share count as of July 23, 2026

Teladoc Health, Inc. (TDOC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Teladoc Health, Inc. (TDOC)
What is Teladoc Health, Inc.'s Market Cap?
Teladoc Health, Inc.'s Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Teladoc Health, Inc.'s Price / Sales?
Teladoc Health, Inc.'s Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Teladoc Health, Inc.'s Revenue (TTM)?
Teladoc Health, Inc.'s Revenue (TTM) is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is Teladoc Health, Inc.'s Net Income (TTM)?
Teladoc Health, Inc.'s Net Income (TTM) is -$177.4M, based on as-reported figures from SEC (XBRL) filings.
What is Teladoc Health, Inc.'s EBITDA?
Teladoc Health, Inc.'s EBITDA is $179.6M, based on as-reported figures from SEC (XBRL) filings.
What is Teladoc Health, Inc.'s Diluted EPS (TTM)?
Teladoc Health, Inc.'s Diluted EPS (TTM) is -0.98, based on as-reported figures from SEC (XBRL) filings.
What is Teladoc Health, Inc.'s EBITDA Margin?
Teladoc Health, Inc.'s EBITDA Margin is 7.2%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TDOCAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-4.0%-2.5%+0.3%-2.2%
Costs and expenses:
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)
Advertising and marketing
Sales
Technology and development
General and administrative
Goodwill impairment
Acquisition, integration, and transformation costs
Restructuring costs
Amortization of intangible assets
Depreciation of property and equipment
Total costs and expenses
% of revenue106.1%110.1%105.6%108.3%
Loss from operations
% of revenue-6.1%-10.1%-5.6%-8.3%
Interest income
Interest expense
Other expense (income), net
Loss before provision for income taxes
Provision for income taxes
Net loss
% of revenue-6.4%-10.4%-3.9%-7.9%
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)